ALFA Finder| Execution period | 12 months |
|---|
NSE filing, NSE: STUDIOLSD. Summary written from the filing by ALFA Finder's alert engine.
Studio LSD Ltd: key numbers
- Share price
- ₹9.00
- Market cap
- ₹46.70 Cr
- Revenue (annual)
- ₹104.5 Cr
- Net profit (annual)
- ₹11.67 Cr
- P/E (TTM)
- 4.0×Sector 28.9×
- Promoter holding
- 73.50%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Studio LSD Ltd
All →Studio LSD Business Update
Studio LSD Limited provided a business update for Q2 FY27, highlighting operational milestones in television episode counts, OTT series production, theatrical film releases, and music catalogue licensing.
Studio LSD Other Announcement
Studio LSD Ltd submitted its Reg 13(3) investor grievance certificate for Q1 FY27. The report shows NIL grievances received, disposed or pending across all channels.
Studio LSD Business Update
Studio LSD Limited appointed Aftertrade Broking Private Limited as an additional market maker. This appointment ensures compliance with compulsory market making requirements.
- Execution
- Up to 24th August, 2028
Studio LSD Partnership
Studio LSD Limited signed a Co-Production Agreement with Jar Pictures Studio LLP for the web series "Rangbaaz S4," commissioned by OTT platform Zee5.
- From
- Jar Pictures Studio LLP
Studio LSD Annual General Meeting
Studio LSD Limited has submitted the voting results and the Scrutinizer's report for its Tenth Annual General Meeting held on September 21, 2026.
Studio LSD Board Meeting Outcome
Studio LSD Limited announced the re-appointment of Mr. Parth Shah as a Whole-time Director and CFO, approved by shareholders at the tenth Annual General Meeting.
Other management change announcements
All →Edelweiss Financial Services Management Change
Promoter director Venkatachalam Ramaswamy resigned as Non-Executive Director and Vice Chairman effective November 11, 2026. He also sought reclassification from promoter to public category, pending approvals.
Abans Financial Services Management Change
Abans Financial Services' Chief Executive Officer Chintan Mehta resigned with immediate effect. Mayank Mundhra was appointed Whole-Time Director from November 11, 2026, subject to shareholder approval.
Ortin Global Management Change
Ortin Global's auditor M/s. Mathesh & Ramana resigned effective 12 Nov 2026, citing other professional commitments. S. D. Mehta and Co. was appointed as replacement.
Tierra Agrotech Management Change
Tierra Agrotech appointed Sridevi Dasari as Executive Director for 60 months, effective 16 November 2026. She is Group Company Secretary and Legal Head of CCL Products (India).
- Execution
- 60 months
National Peroxide Management Change
National Peroxide Limited appointed Mr. Amit Shah as General Manager – Sales & Marketing, effective 11 November 2026, as a senior management personnel change. The appointment was approved at a board meeting held the same day.
Naperol Investments Management Change
Naperol Investments appointed Mr. Vinay Divakar Jayade as Non-Executive Non-Independent Director and Ms. Jinal Shah as Company Secretary, both effective 11 November 2026. Board-approved appointments with no financial value disclosed.
- Execution
- 3 months (Mr. Jayade's term of appointment)